This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.
Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.


This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.

Are you a healthcare professional?

Speaker - Keiichi Fukuda
MD, PhD, Heartseed Inc., Japan

Keiichi Fukuda is pioneer of the cardiac regeneration field and has been at its cutting edge for the past 20 years. He has made several contributions to the regenerative medicine of the failing heart using iPS cells. He developed novel method to purify the cardiomyocytes by metabolic selection. He became Chief Professor of the Department of Cardiology in Keio University, and published more than 800 top-ranked papers. He had established bio-venture company “Heartseed Inc.” in 2015 and became CEO. He is now examining the clinical trial for transplanting human iPS-derived regenerated cardiomyocytes to the patients with congestive heart failure.